• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Comprehensive Overview of 1-Propanoylpiperidine-3-carboxylic Acid (CAS No. 926246-53-9): Properties, Applications, and Research Insights

1-Propanoylpiperidine-3-carboxylic acid (CAS No. 926246-53-9) is a specialized organic compound gaining attention in pharmaceutical and chemical research due to its unique structural features. This piperidine derivative combines a propanoyl group with a carboxylic acid functionality, making it a versatile intermediate for drug discovery and material science. Researchers are increasingly exploring its potential as a building block for bioactive molecules, particularly in targeting neurological and metabolic disorders.

The compound's molecular structure (C9H15NO3) features a piperidine ring substituted at the 3-position with a carboxylic acid and at the 1-position with a propanoyl moiety. This arrangement contributes to its amphiphilic properties, enabling interactions with both polar and non-polar environments—a characteristic highly valued in medicinal chemistry. Recent studies highlight its role in developing small molecule inhibitors, with particular interest in its hydrogen bonding capacity and conformational flexibility.

In the context of current drug development trends, 1-propanoylpiperidine-3-carboxylic acid aligns with the growing demand for heterocyclic compounds that modulate protein-protein interactions. Its structural analogs have shown promise in central nervous system (CNS) drug design, addressing conditions like Parkinson's disease and neuropathic pain. The compound's logP value and water solubility profile make it particularly relevant for optimizing blood-brain barrier permeability—a hot topic in neuroscience research.

From a synthetic chemistry perspective, this compound serves as a valuable chiral precursor for asymmetric synthesis. Its stereocenter at the 3-position allows for the creation of enantiomerically pure derivatives, crucial for developing targeted therapies. Recent publications demonstrate its utility in constructing peptidomimetics and scaffold hopping strategies—techniques frequently searched by computational chemists and pharmacologists.

The spectroscopic characterization of 926246-53-9 reveals distinct NMR signatures (1H NMR: δ 1.05-1.15 (t, 3H), 1.65-1.85 (m, 2H), etc.) and mass spectrometry fragmentation patterns that facilitate its identification in complex mixtures. These analytical data are critical for quality control in contract manufacturing organizations (CMOs), where the compound is increasingly requested for custom synthesis projects.

Environmental and green chemistry applications are emerging for this compound, particularly in biodegradable catalyst systems. Its carboxylate group enables coordination with metal ions, making it a candidate for sustainable chemical processes—a subject of high interest in industrial chemistry forums. Researchers are investigating its potential in organocatalysis and ionic liquid formulations.

In academic settings, 1-propanoylpiperidine-3-carboxylic acid serves as an excellent case study for teaching retrosynthetic analysis and functional group interconversion. Its synthesis typically involves N-acylation of piperidine-3-carboxylic acid derivatives followed by selective protection/deprotection strategies—fundamental techniques in advanced organic synthesis courses.

The compound's crystallographic data (when available) provides insights into molecular packing and hydrogen bonding networks, topics frequently searched by solid-state chemists. These structural features influence its physicochemical properties, including melting point and solubility behavior—critical parameters for formulation scientists.

From a patent landscape perspective, derivatives of 926246-53-9 appear in several intellectual property filings related to kinase inhibitors and GPCR modulators. This reflects the pharmaceutical industry's interest in piperidine-based pharmacophores—a trend corroborated by recent market analysis reports on privileged structures in drug discovery.

Ongoing structure-activity relationship (SAR) studies focus on modifying the propanoyl chain length and carboxylic acid bioisosteres to optimize pharmacokinetic profiles. Such investigations align with current precision medicine approaches that dominate biomedical research discussions.

• 42346-68-9(1-Methyl-5-oxopyrrolidine-3-carboxylic acid)
• 700815-60-7(1-(cyclobutylcarbonyl)piperidine-4-carboxylic Acid)
• 25503-90-6(1-Acetylpiperidine-4-carboxylic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)